low molecular - Globe Thesis

Keyword [low molecular] Result: 41 - 60 \| Page: 3 of 10
41.	Role Of Accessory Signals In The Activation Human Peripheral Blood γδT Cells By Mycobacterium Tuberculosis Low Molecular Peptide In Vitro
42.	Effects Of Low Molecular Weight Heparin And Unfractionated Heparin On VWF,D-dm And CD62P In Patients With Unstable Angina
43.	A Study On The Prethrombotic State In Children With Acute Viral Encephalitis
44.	Comparison Of Unfractionated Heparin And Low-molecular-weight-heparin In Treating Patients With PTE
45.	Study On Quanlity Standard Of Goat Embryo Immunoregulatory Factor (GEIF) Of Low Molecular Weight
46.	Experimental Study On Low Molecular Weight Heparin Therapy For Alkali Burnof The Rat Cornea
47.	Preparation And Biodistribution Of Low-molecular-weight Chitosan Nanoparticles
48.	A Head-to-head Study Of Enoxaparin And Nadroparin In Patients With Acute Coronary Syndrom
49.	Expression Of Adhesion Molecules In The Murine Acute Lung Injury And Beneficial Effects Of Anticoagulation Drugs
50.	Clinical Analysis Of Transient Ischemic Attack
51.	Effect Of Intrapleural Low-molecular-weight Heparin On Pleural Adhesion Induced By Tetracycline In Rabbit
52.	The Relationship Between Structures Of Heparin-Like Glycosamionglycans And Tumor
53.	Research Of The Therapeutic Effect Of Low Molecular Weight Heparin On Rats With Acute Respiratory Distress Syndrome
54.	Preparation Of Low-molecular-weight Chitosan(LMWC) And The Pharmacodynamics Of LMWC Chitosan Nanoparticles Loaded Insulin In Vivo
55.	Effects Of Low-molecular-weight Heparin On Number And Activity Of Endothelial Progenitor Cells From Peripheral Blood
56.	Studies On Controlled Drug Delivery Systems Of Chitosan Oligosaccharide-fatty Acid Graft Copolymer
57.	Expression And Clinical Study Of Hepatocyte Growth Factor In Cerebral Ischemia
58.	Clinical Analysis Of Low Molecular Weight Heparin In Acute Coronary Syndrome
59.	Study Of The LMW-uPA And ATF-Fc Fusion Protein
60.	A Randomized Comparative Study Of The Effects Of Low Molecular Weight Heparin (Fragmin) Or Unfractionated Heparin On Plasma Anti-Xa Activity And Activated Clotting Time During Elective Percutaneous Coronary Intervention
<<First <Prev Next> Last>> Jump to